Therapeutic Class
thumbnail
Therapeutic ClassBayer: Allo- key to cell therapy success but overcoming CMC issues criticalBayer: Allo- key to cell therapy success but overcoming CMC issues critical
Assembling the process, equipment, CMC ecosystem, manufacturing network, and talent are the key elements driving Bayer’s allogeneic cell therapy strategy, the firm says.